These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19847566)

  • 1. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates.
    Azu M; Abrahamse P; Katz SJ; Jagsi R; Morrow M
    Ann Surg Oncol; 2010 Feb; 17(2):558-63. PubMed ID: 19847566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.
    DeSnyder SM; Hunt KK; Dong W; Smith BD; Moran MS; Chavez-MacGregor M; Shen Y; Kuerer HM; Lucci A
    Ann Surg Oncol; 2018 Oct; 25(10):2965-2974. PubMed ID: 29987598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ.
    Katz SJ; Lantz PM; Janz NK; Fagerlin A; Schwartz K; Liu L; Deapen D; Salem B; Lakhani I; Morrow M
    J Clin Oncol; 2005 May; 23(13):3001-7. PubMed ID: 15860856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?
    Edwards BL; Guidry CA; Larson KN; Novicoff WM; Harvey JA; Schroen AT
    Ann Surg Oncol; 2016 Mar; 23(3):782-8. PubMed ID: 26471488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland.
    Tang SS; Kaptanis S; Haddow JB; Mondani G; Elsberger B; Tasoulis MK; Obondo C; Johns N; Ismail W; Syed A; Kissias P; Venn M; Sundaramoorthy S; Irwin G; Sami AS; Elfadl D; Baggaley A; Remoundos DD; Langlands F; Charalampoudis P; Barber Z; Hamilton-Burke WLS; Khan A; Sirianni C; Merker LAG; Saha S; Lane RA; Chopra S; Dupré S; Manning AT; St John ER; Musbahi A; Dlamini N; McArdle CL; Wright C; Murphy JO; Aggarwal R; Dordea M; Bosch K; Egbeare D; Osman H; Tayeh S; Razi F; Iqbal J; Ledwidge SFC; Albert V; Masannat Y
    Eur J Cancer; 2017 Oct; 84():315-324. PubMed ID: 28865259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgeon perspectives about local therapy for breast carcinoma.
    Katz SJ; Lantz PM; Janz NK; Fagerlin A; Schwartz K; Liu L; Deapen D; Salem B; Lakhani I; Morrow M
    Cancer; 2005 Nov; 104(9):1854-61. PubMed ID: 16161056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of consensus guidelines for breast-conserving surgery in patients with ductal carcinoma in situ.
    Tremelling A; Aft RL; Cyr AE; Gillanders WE; Glover-Collins K; Herrmann V; Margenthaler JA
    Cancer Rep (Hoboken); 2022 May; 5(5):e1502. PubMed ID: 34245135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
    Rosenberger LH; Mamtani A; Fuzesi S; Stempel M; Eaton A; Morrow M; Gemignani ML
    Ann Surg Oncol; 2016 Oct; 23(10):3239-46. PubMed ID: 27411549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.
    Shumway DA; McLeod CM; Morrow M; Li Y; Kurian AW; Sabolch A; Hamilton AS; Ward KC; Katz SJ; Hawley ST; Jagsi R
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1237-1245. PubMed ID: 29439886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer.
    DeSnyder SM; Hunt KK; Smith BD; Moran MS; Klimberg S; Lucci A
    Ann Surg Oncol; 2015 Oct; 22(10):3250-6. PubMed ID: 26202554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Margins in breast cancer: How much is enough?
    Pilewskie M; Morrow M
    Cancer; 2018 Apr; 124(7):1335-1341. PubMed ID: 29338088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management.
    Morrow M; Abrahamse P; Hofer TP; Ward KC; Hamilton AS; Kurian AW; Katz SJ; Jagsi R
    JAMA Oncol; 2017 Oct; 3(10):1352-1357. PubMed ID: 28586788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery.
    Valero MG; Mallory MA; Losk K; Tukenmez M; Hwang J; Camuso K; Bunnell C; King T; Golshan M
    Ann Surg Oncol; 2018 Sep; 25(9):2573-2578. PubMed ID: 29786129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.
    Dick AW; Sorbero MS; Ahrendt GM; Hayman JA; Gold HT; Schiffhauer L; Stark A; Griggs JJ
    J Natl Cancer Inst; 2011 Jan; 103(2):92-104. PubMed ID: 21200025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
    Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.